These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 6771001
21. Glutathione transferase-mediated and non-enzymatic activation and detoxication of the N-hydroxy derivative of Trp-P-2, a potent pyrolysate promutagen. Saito K, Yamazoe Y, Kamataki T, Kato R. Xenobiotica; 1984 Jul; 14(7):545-8. PubMed ID: 6506768 [Abstract] [Full Text] [Related]
22. Metabolic activation of trp-P-2, a mutagenic amine from tryptophan-pyrolysate, by liver microsomes from 3-methylcholanthrene-responsive and non-responsive mice. Yamazoe Y, Yamaguchi N, Kamataki T, Kato R. Xenobiotica; 1980 Jul; 10(7-8):483-94. PubMed ID: 7445519 [Abstract] [Full Text] [Related]
23. Metabolic activation of mutagenic tryptophan pyrolysis products (Trp-P-1 and Trp-P-2) by a purified cytochrome P-450-dependent monooxygenase system. Ishii K, Ando M, Kamataki T, Kato R, Nagao M. Cancer Lett; 1980 Jun; 9(4):271-6. PubMed ID: 6772296 [Abstract] [Full Text] [Related]
24. Metabolic activation of the food mutagen 3-amino-1,4-dimethyl-5H-pyrido-[4,3-b]indole (Trp-P-1) in endothelial cells of cytochrome P-450-induced mice. Brittebo EB, Brandt I. Cancer Res; 1994 Jun 01; 54(11):2887-94. PubMed ID: 8187073 [Abstract] [Full Text] [Related]
25. Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2. Raza H, King RS, Squires RB, Guengerich FP, Miller DW, Freeman JP, Lang NP, Kadlubar FF. Drug Metab Dispos; 1996 Apr 01; 24(4):395-400. PubMed ID: 8801053 [Abstract] [Full Text] [Related]
26. Reactions of potent mutagens, 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2) and 2-amino-6-methyl-dipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1) with nucleic acid. Hashimoto Y, Shudo K, Imamura M, Okamoto T. Nucleic Acids Symp Ser; 1980 Apr 01; (8):s109-12. PubMed ID: 7255181 [Abstract] [Full Text] [Related]
27. The in vitro metabolism of halothane (2-bromo-2-chloro-1,1,1-trifluoroethane) by hepatic microsomal cytochrome P-450. Karashima D, Hirokata Y, Shigematsu A, Furukawa T. J Pharmacol Exp Ther; 1977 Nov 01; 203(2):409-16. PubMed ID: 909072 [Abstract] [Full Text] [Related]
28. 3-Methoxy-4-aminoazobenzene, a unique carcinogenic aromatic amine as a substrate for cytochrome-P-450-mediated mutagenesis. Degawa M, Kojima M, Hashimoto Y. Mutat Res; 1985 Nov 01; 152(2-3):125-9. PubMed ID: 3934534 [Abstract] [Full Text] [Related]
29. Regioselectivity and stereoselectivity in the metabolism of trans-1,2-dihydroxy-1,2-dihydrobenz[a]anthracene by rat liver microsomes. Vyas KP, van Bladeren PJ, Thakker DR, Yagi H, Sayer JM, Levin W, Jerina DM. Mol Pharmacol; 1983 Jul 01; 24(1):115-23. PubMed ID: 6865920 [Abstract] [Full Text] [Related]
30. Participation of cytochrome P-450 in reductive metabolism of 1-nitropyrene by rat liver microsomes. Saito K, Kamataki T, Kato R. Cancer Res; 1984 Aug 01; 44(8):3169-73. PubMed ID: 6430544 [Abstract] [Full Text] [Related]
31. Metabolism and activation of aflatoxin B1 by reconstituted cytochrome P-450 system of rat liver. Yoshizawa H, Uchimaru R, Kamataki T, Kato R, Ueno Y. Cancer Res; 1982 Mar 01; 42(3):1120-4. PubMed ID: 6800645 [Abstract] [Full Text] [Related]
32. Specificity of four forms of cytochrome P-450 in the metabolic activation of several aromatic amines and benzo[a]pyrene. Yamazoe Y, Shimada M, Maeda K, Kamataki T, Kato R. Xenobiotica; 1984 Jul 01; 14(7):549-52. PubMed ID: 6438922 [Abstract] [Full Text] [Related]
33. Genotoxic and mutagenic activation of aflatoxin B1 by constitutive forms of cytochrome P-450 in rat liver microsomes. Shimada T, Nakamura S, Imaoka S, Funae Y. Toxicol Appl Pharmacol; 1987 Oct 01; 91(1):13-21. PubMed ID: 3118508 [Abstract] [Full Text] [Related]
34. Characterization of mutagenic glucuronide formation from benzo(a)pyrene in the nonrecirculating perfused rat liver. Kari FW, Kauffman FC, Thurman RG. Cancer Res; 1984 Nov 01; 44(11):5073-8. PubMed ID: 6488167 [Abstract] [Full Text] [Related]
35. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation. Mani C, Gelboin HV, Park SS, Pearce R, Parkinson A, Kupfer D. Drug Metab Dispos; 1993 Nov 01; 21(4):645-56. PubMed ID: 8104124 [Abstract] [Full Text] [Related]
36. N-hydroxylation of carcinogenic and mutagenic aromatic amines. Kato R, Kamataki T, Yamazoe Y. Environ Health Perspect; 1983 Mar 01; 49():21-5. PubMed ID: 6832094 [Abstract] [Full Text] [Related]
37. Mutagen formation in a model beef supernatant fraction. IV. Properties of the system. Taylor RT, Fultz E, Knize M. Environ Health Perspect; 1986 Aug 01; 67():59-74. PubMed ID: 3757961 [Abstract] [Full Text] [Related]
38. The relationship between increases in the hepatic content of cytochrome P-450, form 5, and in the metabolism of aromatic amines to mutagenic products following treatment of rabbits with phenobarbital. Robertson IG, Serabjit-Singh C, Croft JE, Philpot RM. Mol Pharmacol; 1983 Jul 01; 24(1):156-62. PubMed ID: 6865923 [Abstract] [Full Text] [Related]
39. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment. Hissink AM, Oudshoorn MJ, Van Ommen B, Haenen GR, Van Bladeren PJ. Chem Res Toxicol; 1996 Dec 01; 9(8):1249-56. PubMed ID: 8951226 [Abstract] [Full Text] [Related]
40. Identification of new mutagenic heterocyclic amines and quantification of known heterocyclic amines. Wakabayashi K, Kim IS, Kurosaka R, Yamaizumi Z, Ushiyama H, Takahashi M, Koyota S, Tada A, Nukaya H, Goto S. Princess Takamatsu Symp; 1995 Dec 01; 23():39-49. PubMed ID: 8844794 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]